LOGOLOGOLOGOLOGO
  • About us
    • What we do
    • Who we are
      • Governance
      • Staff
      • Vacancies
  • Members
    • EuropaBio Members
    • About Membership
  • How we work
    • Healthcare Biotechnology Council
      • Patient BioForum
      • Study – Impact of the EU’s General Pharmaceutical Legislation
    • Industrial Biotechnology Council
      • EFIB
      • Microorganisms
    • National Associations Council
    • SME Platform
    • Biomanufacturing Platform
      • Biotechnology in our Lives
  • Activities
    • 25 Years of Innovation
    • The EU Biotech Act
    • European Biotech Week
    • EU Projects
      • PRIMED Project
      • APROVALS Project
  • News & Events
    • News
    • Events
  • Library
Become a member
✕

EuropaBio Members nominate Europe’s biotechnology landmarks from the last 25 years

03/07/2021
PRESS RELEASE

Brussels, 5 July 2021

From micro-organism production of the world’s vitamin B2, a revolution in cancer therapy using our own immune systems, and the first Covid mRNA vaccine approved – these are just a few examples of the selected landmarks in biotechnology that were officially announced today as the start of EuropaBio’s 25th Anniversary programme.

To mark a quarter century of impactful biotechnology since EuropaBio launch, members have been nominating important scientific, industry and ecosystem developments that shape our lives now. Today sees publication of almost 30 nominations in the first wave received from Members, with over 50 anticipated by the end of anniversary celebrations in 2021. They recognise brilliant science, innovative companies beakthroughs and a European landscape that enabled new medicines and novel materials.

‘I am thrilled that we received so many excellent nominations from Members, and these show us that biotechnology impacts so many aspects of our lives.. Behind every headline product, are decades of scientific advance from researchers and innovators in the public and private sector. They are, in turn, enabled by the collaborative landscape that Europe has built across borders to amplify strengths and grow together. Our 25th anniversary is a great opportunity not only to celebrate these achievements but also to gather the community and look ahead to the next 25 years.’, says Dr Claire Skentelbery, Director General of EuropaBio.

The anniversary nominations will be amplified through webinars, interviews, conversations on social media discussing some of the key drivers that made them a reality. The year will end with a gala evening in Brussels recognising the best healthcare and industrial biotechnology advances from the anniversary. The ceremony will be followed by a presentation of the 2021 SME Award from EuropaBio, looking to the next generation of landmark biotechnology innovation.

Visit the dedicated anniversary website at www.europabio25.org and follow EuropaBio anniversary celebrations through our weekly newsletter.

EuropaBio Members nominate Europe’s biotechnology landmarks from the last 25 years


Download
Share
Alexandra Simionca
Alexandra Simionca

Related posts

11/07/2025

Industrial Decarbonisation Accelerator Act – EuropaBio Position


Read more
07/07/2025

EuropaBio Position on the Critical Medicines Act


Read more
03/07/2025

Life Sciences Strategy Embraces Biotech for Global Impact


Read more

Important links

  • Industrial Decarbonisation Accelerator Act – EuropaBio Position
  • EuropaBio Position on the Critical Medicines Act

Categories in our Newsroom

EBIO-white

EuropaBio represents corporate and associate members across sectors, plus national and regional biotechnology associations which, in turn, represent over 5000 biotech companies, 4600 out of them are SMEs.

Contact us

Extra links

Members
Staff
Privacy policy
Legal & cookies
Events
Newsroom

Become a member

Media pack

© 2025 Europabio. All Rights Reserved. Designed by EYAS
Become a member

Algal Omega 3

Algal Omega-3 is an innovative feed product for aquaculture. It reduces the impact on climate change by 30-40% compared to fish oil and saves 60 tons of wild fish for every ton of Algal Omega-3 used.

Cheese

Cheese is a vegetarian product thanks to biotechnology. Biotechnology is also essential to produce lactose- or cholesterol-free cheese, as well as alternative proteins.

Clothes

Clothes made from alternative fibres produced by microorganisms can be 8x stronger than steel, 100% recyclable, biodegradable and replace fossil-fuel based or resource-intensive textiles.

Vitamin B2

The biomanufacturing of Vitamin B2 led to the reduction of 75% of fossil raw materials and 50% operating costs, compared to the chemical process. Vitamin B2 is used in the food, feed or healthcare sectors.

Detergents

Enzymes and biosurfactancts are alternative ingredients that improve the performance of detergents, while leading to water and energy savings and reductions in CO2 emissions and water toxicity.

Insulin

Insulin is one of the most widely known biopharmaceutical. Biotechnology revolutionised its manufacturing process and led to the development of new types of insulin through r-DNA technology.